ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,705.41
      0.34%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Incannex Healthcare Ltd (IXHL)

      7. Incannex Healthcare Ltd (IXHL) News

      IXHL

      Incannex Healthcare (IXHL)

      Incannex Healthcare Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IXHL
      DateTimeSourceHeadlineSymbolCompany
      05/30/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      05/30/20247:30AMGlobeNewswire Inc.Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaNASDAQ:IXHLIncannex Healthcare Ltd
      05/07/20247:30AMGlobeNewswire Inc.Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderNASDAQ:IXHLIncannex Healthcare Ltd
      04/16/20248:00AMGlobeNewswire Inc.Incannex Healthcare Inc. Quarterly Update, Q1 2024NASDAQ:IXHLIncannex Healthcare Ltd
      02/28/20247:30AMGlobeNewswire Inc.Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety DisorderNASDAQ:IXHLIncannex Healthcare Ltd
      02/16/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      02/16/20247:30AMGlobeNewswire Inc.Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationNASDAQ:IXHLIncannex Healthcare Ltd
      02/14/20246:16AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IXHLIncannex Healthcare Ltd
      02/01/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      02/01/20247:30AMGlobeNewswire Inc.Clarion Clinics Open for Psychedelic-Assisted TreatmentsNASDAQ:IXHLIncannex Healthcare Ltd
      01/24/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      01/24/20244:05PMGlobeNewswire Inc.Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid ArthritisNASDAQ:IXHLIncannex Healthcare Ltd
      01/18/20249:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      01/18/20248:22AMGlobeNewswire Inc.Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis CommencesNASDAQ:IXHLIncannex Healthcare Ltd
      01/17/20247:30AMGlobeNewswire Inc.Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaNASDAQ:IXHLIncannex Healthcare Ltd
      01/17/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      12/22/20236:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
      12/21/20238:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
      12/21/20238:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
      12/21/20238:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
      12/21/20238:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
      12/21/20234:05PMGlobeNewswire Inc.Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in AustraliaNASDAQ:IXHLIncannex Healthcare Ltd
      12/20/20235:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IXHLIncannex Healthcare Ltd
      12/06/20237:30AMGlobeNewswire Inc.Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep ApneaNASDAQ:IXHLIncannex Healthcare Ltd
      11/29/20231:40PMGlobeNewswire Inc.Incannex Healthcare Announces Completion of its Redomiciliation to the United StatesNASDAQ:IXHLIncannex Healthcare Ltd
      11/16/20239:38AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IXHLIncannex Healthcare Ltd
      11/16/20238:30AMGlobeNewswire Inc.Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASICNASDAQ:IXHLIncannex Healthcare Ltd
      11/08/20236:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IXHLIncannex Healthcare Ltd
      10/26/20236:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IXHLIncannex Healthcare Ltd
      09/08/20237:30AMGlobeNewswire Inc.Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023NASDAQ:IXHLIncannex Healthcare Ltd
       Showing the most relevant articles for your search:NASDAQ:IXHL